Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
3.21
0.13 (4.22%)
At close: Aug 20, 2025, 3:59 PM
3.25
1.24%
After-hours: Aug 20, 2025, 04:43 PM EDT

Cumberland Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-2.93M -3.28M -6.47M -10.86M -10.39M -8.44M -6.32M -2.49M -1.85M -4.08M -5.65M -5.58M -7.74M -5.15M -3.6M -2.13M -45.02K -1.39M
Depreciation & Amortization
5.82M 5.92M 6.04M 5.49M 5.34M 5.12M 4.94M 4.21M 4.51M 4.93M 5.33M 5.89M 5.42M 5.03M 4.61M 4.75M 4.87M 4.82M
Stock-Based Compensation
306.08K 297.35K 301.89K 320.98K 327.72K 353.64K 365.04K 398.05K 503.39K 377.76K 447.5K 545.38K 519.1K 738.81K 741.87K 758.26K 858.51K 944.9K
Other Working Capital
296.26K -425.25K 176.34K -557.26K -1.85M -2.47M -2.47M -2M 561.56K 928.36K 644.92K -400.29K -2.18M -1.72M -1.38M -121.22K -456.05K -670.08K
Other Non-Cash Items
-2.35M 1.46M 5.5M 15.06M 16.22M 14.07M 7.75M -5.19M -3.19M -5.44M -2.71M -1.6M -2.1M -1.96M -3.39M -227.57K -1.88M -2.99M
Deferred Income Tax
n/a n/a n/a -5.27M -5.27M -5.27M -5.27M 48.15K 55.05K 61.95K 61.95K 517.12K 1.01M -688.23K -192.82K -674.33K -376.47K 1.35M
Change in Working Capital
6.27M 4.95M 2.43M 2.19M 1.47M 4.04M 4.63M 10.91M 10.06M 11.33M 10.97M 7.79M 6.93M 6.43M 8.18M 2.75M 2.77M 3.57M
Operating Cash Flow
7.12M 5.42M -612.19K -1.48M -715.64K 5.38M 6.09M 7.9M 10.09M 7.19M 8.45M 7.57M 4.04M 4.41M 6.34M 5.24M 6.2M 6.31M
Capital Expenditures
-60.11K -80.43K -90.99K -150.9K -286.78K -336.78K -453.05K -1.21M -2.13M -2.21M -2.07M -1.31M -402.1K -278.02K -354.46K -486.37K -1.51M -1.66M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a 13.5M 13.5M 13.5M n/a -13.5M -13.5M -13.5M n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -200K -200K -200K -200K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-743.9K -1.1M 68.11K 439.99K 249.23K 264.25K 213.62K -12.63M -11.69M -11.7M -11.65M 901.67K -45.97K -44.07K -328.04K -485.36K 23.82K -116.44K
Investing Cash Flow
-779.49K -1.11M 57.84K 345.29K 60.58K 10.57K -105.69K -213.05K -231.23K -307.01K -13.67M -13.85M -13.85M -13.73M -501.89K -791.12K -1.35M -1.5M
Debt Repayment
-10.85M -10.84M 2.49M 3.17M 2.94M 11.86K -3.42M -4.78M -5.85M -3.93M 1.2M 2.7M 5M 5M n/a -2M -3M -3.5M
Common Stock Repurchased
-450.24K -577.31K -579.05K -669.64K -772.47K -801.02K -740.53K -741.22K -614.66K -660.03K -1.05M -1.22M -1.4M -1.66M -1.39M -1.33M -1.42M -1.71M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.71M 3.67M -1.72M -2.41M -2.43M -2.43M -3.27M -3.2M -3.36M -3.17M -2.21M -1.49M -1.24M -1.67M -2.17M -1.92M -2.13M -1.7M
Financial Cash Flow
-7.59M -7.75M 196.9K 88.18K -257.58K -3.22M -7.42M -8.72M -9.83M -7.76M -2.06M -16.26K 2.36M 1.66M -3.55M -5.25M -6.55M -6.91M
Net Cash Flow
-1.25M -3.44M -357.44K -1.04M -912.64K 2.16M -1.44M -1.03M 32.52K -880.62K -7.28M -6.3M -7.45M -7.66M 2.29M -803.3K -1.7M -2.1M
Free Cash Flow
7.06M 5.34M -703.17K -1.63M -1M 5.04M 5.64M 6.68M 7.96M 4.98M 6.38M 6.26M 3.64M 4.13M 5.99M 4.75M 4.69M 4.65M